Medical Facilities Corporation Announces Second Quarter Results and New $40 Million Credit Agreement

Executive Summary

• Medical Facilities Corporation reported its financial results for the three and six months ended June 30, 2025, highlighting a significant drop in net income for Q2 due to operational challenges at Sioux Falls Specialty Hospital (SFSH), specifically the relocation of its primary physician group.
• The company entered into a new $40 million revolving credit facility with CIBC, replacing a previous $50 million agreement, to provide future financial flexibility.
• Despite the headwinds at SFSH, the company's other facilities demonstrated strong performance with improved profitability, higher volumes, and beneficial case/payor mix.

Key Details

• Q2 2025 Financial Highlights (Continuing Operations):
  • Facility Service Revenue: $80.6 million (decrease of 1.3% YoY); excluding SFSH, revenue increased 6.5%.
  • Surgical Case Volumes: Decreased 0.9% YoY; excluding SFSH, volumes increased 0.1%.
  • Income from Operations: $12.0 million (decrease of 5.0% YoY); excluding SFSH, income from operations increased 98.9%.
  • EBITDA: $16.0 million (decrease of 4.7% YoY).
  • Net Income: $9.6 million (up 375.1% YoY), driven by lower non-cash finance costs and tax variations, though operational income was impacted by SFSH.
  • EPS: Basic $0.24 (vs. $(0.11) in Q2 2024); Fully Diluted $0.20 (vs. $(0.11) in Q2 2024).
• SFSH Operational Impact:
  • The relocation of the primary physician group's clinic (largest orthopedic referral base) negatively impacted case volume and payor mix.
  • This resulted in fewer high-acuity surgical cases and less favorable revenue metrics for SFSH.
• Financing Activity:
  • Entered into a new $40 million revolving credit facility with CIBC on August 6, 2025, maturing August 4, 2028.
  • The facility includes an option to increase by up to $25 million subject to conditions.
  • Replaces the previous $50 million credit agreement dated August 31, 2022.
  • Secured by general security agreements, securities pledge agreements, and guarantees from MFC and wholly-owned subsidiaries.
• Shareholder Returns & Capital Structure:
  • Returned $6.9 million to shareholders via the purchase of 609,100 common shares under the normal course issuer bid.
  • Paid a quarterly cash dividend of C$0.09 per common share (C$0.36 annualized).
  • Balance Sheet (June 30, 2025): Consolidated net working capital of $36.6 million; Cash and cash equivalents of $49.0 million.
  • Cash Flow Drivers: Decrease in cash primarily due to the substantial issuer bid completion in March 2025 and a $14.4 million tax payment in April 2025 related to the sale of Black Hills Surgical Hospital.
• Distributable Cash Flow:
  • Cash available for distribution (C$): $5.3 million (Q2 2025) vs $9.3 million (Q2 2024).
  • Distributions per common share: $0.089 (Q2 2025) vs $0.089 (Q2 2024).
  • Payout ratio: 32.4% (Q2 2025) vs 23.3% (Q2 2024).

Notable Quotes

• "The relocation of a key physician group's clinic, which is the largest orthopedic referral base for SFSH, contributed to fewer high-acuity surgical cases performed at SFSH and a less favourable case/payor mix," said Jason Redman, President and CEO. "While this relocation adversely impacted SFSH's facility service revenue and income from operations for the quarter, we look forward to the return of normalized operations in the back half of the year. Meanwhile, our other hospitals had a strong quarter with improved profitability, benefiting from higher volumes, beneficial case and payor mix, and payor rate increases. Subsequent to quarter end, we entered into a new, favourable $40 million credit agreement that provides future flexibility if needed."